These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 154893)

  • 61. Long-term effects of dichloromethylene diphosphonate (CI2MDP) on skeletal lesions in multiple myeloma.
    Delmas PD; Charhon S; Chapuy MC; Vignon E; Briancon D; Edouard C; Meunier PJ
    Metab Bone Dis Relat Res; 1982; 4(3):163-8. PubMed ID: 6218370
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effects of disodium dichloromethylene diphosphonate on Paget's disease of bone.
    Meunier PJ; Chapuy MC; Alexandre C; Bressot C; Edouard C; Vignon C; Mathieu L; Trechsel U
    Lancet; 1979 Sep; 2(8141):489-92. PubMed ID: 90215
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Ethane 1-hydroxy-1, 1-diphosphonate (EHDP) counteracts the inhibitory effect of uranyl nitrate on bone formation.
    Ubios AM; Guglielmotti MB; Cabrini RL
    Arch Environ Health; 1990; 45(6):374-7. PubMed ID: 2125406
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Resorption is not essential for the stimulation of bone growth by hPTH-(1-34) in rats in vivo.
    Hock JM; Hummert JR; Boyce R; Fonseca J; Raisz LG
    J Bone Miner Res; 1989 Jun; 4(3):449-58. PubMed ID: 2527459
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Drug treatment of primary hyperparathyroidism: use of clodronate disodium.
    Douglas DL; Kanis JA; Paterson AD; Beard DJ; Cameron EC; Watson ME; Woodhead S; Williams J; Russell RG
    Br Med J (Clin Res Ed); 1983 Feb; 286(6365):587-90. PubMed ID: 6218861
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Slow-release clodronate in prevention of inflammation and bone loss associated with adjuvant arthritis.
    Osterman T; Virtamo T; Laurén L; Kippo K; Pasanen I; Hannuniemi R; Väänänen K; Sellman R
    J Pharmacol Exp Ther; 1997 Feb; 280(2):1001-7. PubMed ID: 9023317
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effect of minodronic acid (ONO-5920) on bone mineral density and arthritis in adult rats with collagen-induced arthritis.
    Yamane I; Hagino H; Okano T; Enokida M; Yamasaki D; Teshima R
    Arthritis Rheum; 2003 Jun; 48(6):1732-41. PubMed ID: 12794842
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Long term effects of dichloromethylene diphosphonate in Paget's disease of bone.
    Delmas PD; Chapuy MC; Vignon E; Charhon S; Briancon D; Alexandre C; Edouard C; Meunier PJ
    J Clin Endocrinol Metab; 1982 Apr; 54(4):837-44. PubMed ID: 6460781
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Prostaglandins in inflammatory bone pathology: mechanism and therapeutic benefit of etodolac.
    Hayward MA; Howard GA; Neuman RG; Wood DD; Weichman BM; Van Sickle DC
    Agents Actions; 1989 Mar; 26(3-4):310-8. PubMed ID: 2525314
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Fenofibrate vs pioglitazone: Comparative study of the anti-arthritic potencies of PPAR-alpha and PPAR-gamma agonists in rat adjuvant-induced arthritis.
    Koufany M; Jouzeau JY; Moulin D
    Biomed Mater Eng; 2014; 24(1 Suppl):81-8. PubMed ID: 24928921
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Diphosphonates: aimed in a chemical sense.
    Lancet; 1981 Dec; 2(8259):1326-8. PubMed ID: 6118722
    [No Abstract]   [Full Text] [Related]  

  • 72. Effects of disodium dichloromethylene diphosphonate on hypercalcemia produced by bone metastases.
    Chapuy MC; Meunier PJ; Alexandre CM; Vignon EP
    J Clin Invest; 1980 May; 65(5):1243-7. PubMed ID: 6444955
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Studies on anti-inflammatory agents. (5). Specific characteristic of bone changes in adjuvant arthritic rats with passage of time].
    Fukawa K; Kanezuka T; Ohba S; Irino O
    Nihon Yakurigaku Zasshi; 1985 May; 85(5):407-14. PubMed ID: 4029811
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Effects of ethane-1-hydroxy-1,1-diphosphonate (EHDP) upon the kinetics of bone resorption and bone formation at the whole bone level in prelabelled chicks.
    Klein L; Wong KM
    Calcif Tissue Int; 1983 Jul; 35(4-5):602-8. PubMed ID: 6413043
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The protective effects of incadronate on inflammation and joint destruction in established rat adjuvant arthritis.
    Zhao H; Liu S; Huang D; Xu Q; Shuto T; Iwamoto Y
    Rheumatol Int; 2006 Jun; 26(8):732-40. PubMed ID: 16237529
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Endocrine and pharmacological suppressors of bone turnover protect against osteopenia in ovariectomized rats.
    Wronski TJ; Dann LM; Scott KS; Crooke LR
    Endocrinology; 1989 Aug; 125(2):810-6. PubMed ID: 2502377
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The use of diphosphonates in myeloma.
    Kanis JA; Paterson AD; Russell RG
    Br J Haematol; 1983 Apr; 53(4):688-90. PubMed ID: 6219695
    [No Abstract]   [Full Text] [Related]  

  • 78. The effect of disodium ethane-1-hydroxy-1,1-diphosphonate (EHDP) on a rabbit model of athero-arteriosclerosis.
    Rosenblum IY; Flora L; Eisenstein R
    Atherosclerosis; 1975; 22(3):411-24. PubMed ID: 812508
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Pharmacological investigations of the new antiinflammatory agent 2-(10,11-dihydro-10-oxodibenzo[b,f]thiepin-2-yl]propionic acid. 4th communication: inhibitory effects on rat adjuvant arthritis.
    Tsurumi K; Kokuba S; Okada K; Yanagihara M; Fujimura H
    Arzneimittelforschung; 1986 Dec; 36(12):1810-7. PubMed ID: 3566842
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Bisphosphonate treatment of bone metastases and hypercalcemia of malignancy.
    Coleman RE
    Oncology (Williston Park); 1991 Aug; 5(8):55-60; discussion 60-2, 65. PubMed ID: 1834153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.